Category Archives: Neuroscience

An algorithm that learns through rewards may show how our brain does too – MIT Technology Review

In 1951, Marvin Minsky, then a student at Harvard, borrowed observations from animal behavior to try to design an intelligent machine. Drawing on the work of physiologist Ivan Pavlov, who famously used dogs to show how animals learn through punishments and rewards, Minsky created a computer that could continuously learn through similar reinforcement to solve a virtual maze.

At the time, neuroscientists had yet to figure out the mechanisms within the brain that allow animals to learn in this way. But Minsky was still able to loosely mimic the behavior, thereby advancing artificial intelligence. Several decades later, as reinforcement learning continued to mature, it in turn helped the field of neuroscience discover those mechanisms, feeding into a virtuous cycle of advancement between the two fields.

In a paper published in Nature today, DeepMind, Alphabets AI subsidiary, has once again used lessons from reinforcement learning to propose a new theory about the reward mechanisms within our brains. The hypothesis, supported by initial experimental findings, could not only improve our understanding of mental health and motivation. It could also validate the current direction of AI research toward building more human-like general intelligence.

Sign up for The Algorithm artificial intelligence, demystified

At a high level, reinforcement learning follows the insight derived from Pavlovs dogs: its possible to teach an agent to master complex, novel tasks through only positive and negative feedback. An algorithm begins learning an assigned task by randomly predicting which action might earn it a reward. It then takes the action, observes the real reward, and adjusts its prediction based on the margin of error. Over millions or even billions of trials, the algorithms prediction errors converge to zero, at which point it knows precisely which actions to take to maximize its reward and so complete its task.

It turns out the brains reward system works in much the same waya discovery made in the 1990s, inspired by reinforcement-learning algorithms. When a human or animal is about to perform an action, its dopamine neurons make a prediction about the expected reward. Once the actual reward is received, they then fire off an amount of dopamine that corresponds to the prediction error. A better reward than expected triggers a strong dopamine release, while a worse reward than expected suppresses the chemicals production. The dopamine, in other words, serves as a correction signal, telling the neurons to adjust their predictions until they converge to reality. The phenomenon, known as reward prediction error, works much like a reinforcement-learning algorithm.

DeepMinds new paper builds on the tight connection between these natural and artificial learning mechanisms. In 2017, its researchers introduced an improved reinforcement-learning algorithm that has since unlocked increasingly impressive performance on various tasks. They now believe this new method could offer an even more precise explanation of how dopamine neurons work in the brain.

Specifically, the improved algorithm changes the way it predicts rewards. Whereas the old approach estimated rewards as a single numbermeant to equal the average expected outcomethe new approach represents them more accurately as a distribution. (Think for a moment about a slot machine: you can either win or lose following some distribution. But in no instance would you ever receive the average expected outcome.)

The modification lends itself to a new hypothesis: Do dopamine neurons also predict rewards in the same distributional way?

To test this theory, DeepMind partnered with a group at Harvard to observe dopamine neuron behavior in mice. They set the mice on a task and rewarded them based on the roll of dice, measuring the firing patterns of their dopamine neurons throughout. They found that every neuron released different amounts of dopamine, meaning they had all predicted different outcomes. While some were too optimistic, predicting higher rewards than actually received, others were more pessimistic, lowballing the reality. When the researchers mapped out the distribution of those predictions, it closely followed the distribution of the actual rewards. This data offers compelling evidence that the brain indeed uses distributional reward predictions to strengthen its learning algorithm.

DeepMind

This is a nice extension to the notion of dopamine coding of reward prediction error, wrote Wolfram Schultz, a pioneer in dopamine neuron behavior who wasnt involved in the study, in an email. It is amazing how this very simple dopamine response predictably follows intuitive patterns of basic biological learning processes that are now becoming a component of AI.

The study has implications for both AI and neuroscience. First, it validates distributional reinforcement learning as a promising path to more advanced AI capabilities. If the brain is using it, its probably a good idea, said Matt Botvinick, DeepMinds director of neuroscience research and one of the lead authors on the paper, during a press briefing. It tells us that this is a computational technique that can scale in real-world situations. Its going to fit well with other computational processes.

Second, it could offer an important update to one of the canonical theories in neuroscience about reward systems in the brain, which in turn could improve our understanding of everything from motivation to mental health. What might it mean, for example, to have pessimistic and optimistic dopamine neurons? If the brain selectively listened to only one or the other, could it lead to chemical imbalances and induce depression?

Fundamentally, by further decoding processes in the brain, the results also shed light on what creates human intelligence. It gives us a new perspective on what's going on in our brains during everyday life, Botvinick said.

Read the original post:
An algorithm that learns through rewards may show how our brain does too - MIT Technology Review

Global Neuroscience Market Will Grow Over USD 34800 million by 2024 – TheInfobiz

Zion Market Researchincludes new market research reportGlobal Neuroscience Market Expected to Reach USD 34,800 million by 2024to its huge collection ofresearch reports.TheNeuroscience Marketreport presents an all-inclusive approach to the Neuroscience Market growth along with a defined and methodical examination of the overall market. To start with, the report provides better insights of the competitive landscape of the global Neuroscience Market and also puts forth the several prominent market players along with their profiles.

This Research will help you grow your Business: [Download free Sample PDF of This Research Report]

Our Free Complimentary Sample Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology

The global market 2020reportNeuroscience Marketincludes identifying and comparing major competitors

For this, the Neuroscience Market report covers the company overview, financial metrics, tactics, business strategies, trends, acquisitions, and merger of the key participants active in the global Neuroscience Market. Further, the analysis offers a thorough evaluation of the latest key trends and technologies playing an imperative part in the Neuroscience Market growth.

Moreover, a range of characteristics such as challenges, opportunities, restraints, and drivers are taken into consideration, which has an impact on market growth. To offer such a comprehensive assessment of the market, numerous competent analytical tools are used. The Neuroscience Market report covers every part related to the globe Neuroscience Market and its development. Moving further from the primary data, the report advances to present the market segmentation based on diverse factors such as [Product, Applications, End-Users, and Major Regions].

Download Free PDF Report Brochure @https://www.zionmarketresearch.com/requestbrochure/neuroscience-market

Also, the report will provide an in-depth analysis of future prospects as well as market penetration. A methodical approach is being mentioned in the report for each product and application such as which application is developing at a remarkable rate and which product has the utmost penetration.

To provide one with insightful data of the market scope globally, the analysis also evaluates sub-segments and key regions [Latin America, North America, Asia Pacific, Middle & East Africa, and Europe] of the Neuroscience Market. Furthermore, it assesses the market by evaluating the manufacturers, suppliers, supply chain, or value chain management. The regional markets also assessed by evaluating the products pricing, production capacity, demand, logistics, supply, as well as the historical performance in a specific region of the Neuroscience Market.

Promising Regions & Countries Mentioned In The Neuroscience Market Report:

Browse Press Release:https://www.zionmarketresearch.com/news/neuroscience-market

Some of the key questions answered in this report:

Inquire more about this report @https://www.zionmarketresearch.com/inquiry/neuroscience-market

In order to get a deeper view of Neuroscience Market Size, competitive landscape is provided i.e. Revenue (Million USD) by Players (2015-2025), Revenue Market Share (%) by Players (2015-2025) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.

Purposes Behind Buying Neuroscience Market Report:-

Also, Research Report Examines:

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Read the original post:
Global Neuroscience Market Will Grow Over USD 34800 million by 2024 - TheInfobiz

CCST introduces expanded class of 2020 CCST Science & Technology Policy Fellows, now placed in the Legislative and Executive Branch | California…

Interested in becoming a CCST Science & Technology Policy Fellow? CCST is currently accepting applications for the 2021 class year until March 1st.

SACRAMENTO, CAWe are proud to introduce the2020 Classof CCST Science & Technology Policy Fellows a program that trains scientists and engineers for careers in public policy, while helping to equip Californias decision makers with science-savvy staff.

This year, the CCST Science Fellows class was expanded to 15 fellows and, in a historic first for the program, five CCST Science Fellows were placed in the Executive Branch working in California State Agencies and the Governors office. This is in addition to the 10 CCST Science Fellows who were placed in the California State Legislature and are working in policy committees and member offices.

The expansion of the fellowship program was made possible by a major investment from the State of Californiachampioned by the California State Legislature and approved by Governor Newsomas well as continued philanthropic support.

Our2020 CCST Science Fellowshave completed PhD research at the likes ofUC Berkeley, UC Davis, UC Irvine, UCLA, UC San Diego, UC Santa Barbara, University of Washington, University of Utah, Cornell University, Harvard University, Penn State University, Emory University, University of Florida,University of Virginia,and the Rockefeller University.

Their technical expertise spans fields including the use of plants to learn about atmospheric pollution, materials for hydrogen fueled vehicles, crop disease, impacts of US air quality regulations, nanoparticles, efficient solar panels, effects of air pollution on pollination, how animals process odors, Alzheimers, novel birth control products, and antibiotic resistance genes.

These fifteen PhD scientists reported to our downtown Sacramento headquartersin November to participate inour annual policy boot camp a crash course on the process, history, and landscape of California policymaking, as well as skills development and communications workshops to prepare them for the intense, dynamic pace of the Capitol policy world.

Who are these talented, passionate professionals, and whichoffices are they working in now?

Lets meet our2020 CCST Science Fellows:

LaShaye Cobley | California Air Resources BoardPhD: Biology, University of Utah

Brynn Cook | Office of Senator GonzalezPhD: Ecology, University of Virginia

Sierra Cook | Assembly Education CommitteePhD: Applied Physics, Cornell University

May Dobosiewicz | Assembly Water, Parks, & Wildlife CommitteePhD: Neuroscience, The Rockefeller University

Grayson Doucette | Senate Natural Resources and Water CommitteePhD: Materials Science, Penn State University

Rae Eaton | California Natural Resources AgencyPhD: Chemistry, University of Washington

Cristina Echeverria | Strategic Growth CouncilPhD: Civil and Environmental Engineering, UCLA

Geoff Hollett | Office of Senator ArchuletaPhD: Materials Science and Engineering, UC San Diego

Jacy Hyde | Assembly Natural Resources CommitteePhD: Forest Resources and Conservation, University of Florida

Ken McCullough | Governors Office of Planning and Research / Office of Surgeon GeneralPhD: Neuroscience, Emory University

Maria Montchal | Senate Environmental Quality CommitteePhD: Biological Sciences, UC Irvine

Rachel Silvern | Assembly Environmental Safety & Toxic Materials CommitteePhD: Earth and Planetary Sciences, Harvard University

Nikki Soltis | Governors Office of Business and Economic DevelopmentPhD: Plant Biology, UC Davis

Meron Tesfaye | Senate Budget and Fiscal Review CommitteePhD: Chemical Engineering, UC Berkeley

Emily Wonder | Assembly Judiciary CommitteePhD: Materials, UC Santa Barbara

About CCST

CCST is a nonpartisan nonprofit created via the California Legislature in 1988 to provide objective advice from Californias leading scientists and research institutions on policy issues involving science. Californias policies are stronger with science, and CCST is uniquely qualified as an expert organization, modeled after the National Academies of Sciences, to convene a statewide network of experts across disciplines and institutions.

Link:
CCST introduces expanded class of 2020 CCST Science & Technology Policy Fellows, now placed in the Legislative and Executive Branch | California...

Science teacher brings real life experience into the classroom | EXCEL – KENS5.com

SAN ANTONIO Just about every month for the last two years, Dr. Jerome Choate was voted by students at his school as best teacher. So it was an easy choice for Randolph ISD to nominate him for the KENS 5 Credit Human EXCEL award.

At Randolph High school, Its not Choates PhD and years of research in neuroscience that sets him apart. He is in fact a star for many other reasons.

There was a lot of energy in the cafeteria of Randolph High School on Tuesday.

It all had al the right elements of family, friends and fans (aka students), to make it a very special day for their favorite Science teacher, Dr. Jerome Choate.

Cheers, clapping and emotion filled the room as Dr. Choate accepted his EXCEL award.

This is only necessary because of the students, my kids who are out here, give yourselves a hand, said Dr. Choate as he addressed the room.

Choates love for everything earth and science goes back to his childhood.

He received a B.S. in Biology from Oregon State University in 1983. Then he earned a Ph.D. in Neuroscience at the University of Texas Medical Branch at Galveston in 1989.

Choate went on to work as a Post-Doctoral Research Fellow at the Oregon Health Sciences University for 6 years, then as a contract Staff Chemist at Wilford Hall Medical Center for 3 years.

He also taught for 2 years at the University of Alaska Anchorage in the departments of Chemistry and Biological Sciences.

But once again, like most military spouses, he found himself making another move as his wife continued to serve in the Air Force.

Six years ago, their family returned to San Antonio.

Weve been together 32 years, almost 33 Dr. Choates wife, Nicola, said.

While Nicola served in the Air Force, she and Choate traveled all over the country, hopping from state to state with their four girls.

Along the way, together they would journey into the different state parks.

He does like to camp, said one of his high school students.

Apparently Choate likes to share his camping stories with his class, In San Antonio you think it's all limestone. you only have to get far away and there are other neat formations like enchanted rock. and many students have been there and we talk about it."

His students love how he brings a piece of home-life to the class because as they explained, he makes a difficult subject, much more interesting.

"It's just the way he explains things is what I like most about him, said another Junior at Randolph High School.

It creates a positive environment for these sophomores, juniors and seniors already prepping for College. Dr. Choate also teaches their UT OnRamps course, a dual enrollment class.

And just like hes striving to make them great students, "The students make you a good teacher, " Choate added, "You're doing it for them. You're not doing it for you. Your ego, your personal aspirations have nothing to do with how you're going to teach them."

RELATED: Lackland ISD teacher wins KENS 5 Credit Human EXCEL award

RELATED: Carissa Livingston wins KENS 5 Credit Human EXCEL Award for Schertz-Cibolo-Universal City ISD

RELATED: Angie D'Ambosio wins EXCEL award for North East ISD

Read the rest here:
Science teacher brings real life experience into the classroom | EXCEL - KENS5.com

Study links Alzheimer’s disease with circular RNA – National Institute on Aging

Certain loops of ribonucleic acid circular RNAs in the brain are associated with the development of Alzheimers disease, according to a study reported recently in Nature Neuroscience. Because these circular RNAs can be detected not just in the brain but in cerebrospinal fluid and blood, they have the potential to be developed into lab tests to detect Alzheimers before symptoms appear.

RNAs are the molecules that carry instructions from genes to create proteins in the body. Most research has been done with the linear form, and scientists are just beginning to learn how the body uses circular RNA, especially in the brain. Using modern sequencing technologies, investigators at Washington University in St. Louis analyzed the complete RNA content in brain samples and compared circular RNAs in people with and without Alzheimers disease.

The investigators first compared the RNA sequences from brain tissue donated by 83 people who had Alzheimers with samples from 13 healthy people. Then they compared the RNA sequences from brain tissue samples from 89 people with Alzheimers, 66 probable or possible cases, and 40 controls obtained from the NIA-supported Accelerating Medicines PartnershipAlzheimers Disease (AMP-AD) Biomarkers Project.

In each of these two datasets, more than 3,500 circular RNAs were detected and analyzed. The researchers discovered that certain circular RNAs are strongly associated with the development of Alzheimers. In the first dataset, three circular RNAs, including one known as circHOMER1, were significantly associated with three Alzheimers traits: having a diagnosis of Alzheimers, a quantitative measure of dementia severity at the end of life, and the number and distribution of tau tangles throughout the brain.

The second dataset replicated those findings: 28 circular RNAs, including circHOMER1, were significantly associated with all three traits. Together, these findings suggest there is a significant association between the expression of certain circular RNAs like circHOMER1 in the brain and Alzheimers traits.

Next, the research team analyzed circular RNAs in samples from 21 brains donated by people with early-onset Alzheimers who were part of the NIA-supported Dominantly Inherited Alzheimer Network, which is a study to identify biomarkers to predict the development of Alzheimers. In these people with early-onset disease, the magnitude of changes in RNA expression was even greater than in the first two datasets. This finding suggests even more strongly that the correlation between certain circular RNAs and disease is meaningful and not merely a coincidence. However, it is not enough to suggest causation.

The investigators also analyzed circular RNAs in samples from people who had mild or no dementia but whose brains showed signs of Alzheimers. After comparing results to those from healthy controls and those with dementia from Alzheimers, the research team found evidence for early changes in circular RNA before the people had substantial symptoms of Alzheimers.

Taken together, these results suggest that specific circular RNAs might have the potential for use as biomarkers to detect Alzheimers disease before symptoms appear. Future studies are needed to better understand the functions of the circular RNAs identified in these analyses.

This research was supported in part by NIA grants R01AG044546, P01AG003991, RF1AG053303, R01AG058501, U01AG058922, RF1AG058501, R01AG057777, K01AG046374, K23AG049087, P50AG05681, P01AG03991, P01AG026276 and UF1AG032438.

These activities relate to NIAs AD+ADRD Research Implementation Milestones: Milestone 2.A Disease Mechanisms and Milestones 9.B and 9.F Biomarkers.

Reference:

Dube U, et al. An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nature Neuroscience. 2019; 22(11):1903-1912. doi: 10.1038/s41593-019-0501-5.

Read more here:
Study links Alzheimer's disease with circular RNA - National Institute on Aging

Beebe Healthcare expands partnership with Jefferson Neuroscience Network – Milford Beacon

Beebe Healthcare announced it will expand its partnership with the Thomas Jefferson Neuroscience Network, to include a robotic teleconferencing unit in Beebes Emergency Department.

The Jefferson Expert Teleconsulting, or JET, unit is the regions first university-based, high-tech mobile robot system for acute stroke.

When a patient comes into Beebes Emergency Department with a suspected stroke, the emergency teams spring into action to run tests and get a medical history on the patient. As soon as a stroke is suspected, the JET protocol is started.

In addition to being used for patients who come in through the Emergency Department, the JET protocol will also be used for patients who have a stroke while already admitted to the hospital.

The stroke robot provides Jefferson Network hospitals with 24/7 access to vascular neurologists and neurosurgeons for emergency consultation services. The goal is to complement the care provided by community neurologists and/or emergency physicians to those patients presenting with symptoms of a stroke.

The process starts with a phone call from Beebes emergency team to the Jefferson Neuroscience Network to reach the on-call stroke neurologist.

Then the neurologist connects with the Beebe team via a mobile robotic system in the emergency room. The mobile robotic system allows the neurologist to speak directly to the team, the patient, and family members via secure videoconference technology. This allows the Jefferson neurologist to gather information, as well as to conduct a neurologic examination on the patient. The Jefferson neurologist can also review test results and medical history while on the teleconference.

This system allows us to be more efficient when treating stroke patients, said Nick Perchiniak, of Sussex Emergency Associates, the team providing care in Beebes Emergency Department. When it comes to stroke, time is brain, so it is very important to be able to diagnose and treat a stroke patient quickly. The Jefferson robot allows us to have quick access to their neurology experts within minutes of a patients arrival.

Once the immediate treatment plan is put into action, the Beebe and Jefferson medical teams are able to make decisions about the best next steps for the patient, including transport to Jefferson if necessary.

This is going to be especially helpful at our new South Coastal Health Campus Emergency Department, said Perchiniak. We will have the mobile robot there as well so that if a patient comes in with a possible stroke, we can activate a stroke consultation with Jefferson quickly and get the patient the help they need.

From South Coastal, patients could be taken by helicopter to Jefferson or to Beebes Margaret H. Rollins Lewes Campus. In Lewes, the patient could also be taken by helicopter to Jefferson.

In addition to the Jefferson stroke robot and videoconference system, Beebes Emergency Department also uses similar technology or telemedicine for psychiatric or behavioral health patients to connect with specialists in the region, and for children, the Emergency Department is able to teleconference with pediatric specialists at A.I. duPont/Nemours.

This takes our relationship with Jefferson to a new level, said Lynn Toth, cardiovascular medical specialist at Beebe. It will be a great resource for both our medical teams and for the community. The program gives us nearly immediate access to renowned stroke experts, which can only improve the way we care for our community.

For more, visit beebehealthcare.org.

More here:
Beebe Healthcare expands partnership with Jefferson Neuroscience Network - Milford Beacon

Could we ever create an AI as smart as the human brain? – Telegraph.co.uk

For the last three decades our best models of reinforcement learning in AI and neuroscience have focused almost entirely on learning to predict the average future reward, he says.

But this doesnt reflect real life when playing the lottery, for example, people expect to either win big, or win nothing no one is thinking about getting the average outcome.

The work has significance in some key areas. For one, it could lift the lid on whats happening neurologically with conditions like addiction and depression.

If some neurons are reducing dopamine, or, as Dabney puts it, thinking in pessimistic terms, there may be a situation in which they take the reins, shifting the brains entire outlook to a pessimistic one. Seems like a pretty good characterisation of what depression involves, he says.

The finding is also a rare example of AI shedding light on the way the brain works, validating the work being done by researchers to get AI to work just as the brain does. And with researchers expecting this to be a more common occurrence over the next decade, there could be an acceleration in the understanding of the way the brain works, and the subsequent advancement of AI.

View post:
Could we ever create an AI as smart as the human brain? - Telegraph.co.uk

Connecting Fear and Reward in the Mammalian Brain – Technology Networks

When you expect a really bad experience to happen and then it doesnt, its a distinctly positive feeling. A new study of fear extinction training in mice may suggest why: The findings not only identify the exact population of brain cells that are key for learning not to feel afraid anymore, but also show these neurons are the same ones that help encode feelings of reward.

The study specifically shows that fear extinction memories and feelings of reward alike are stored by neurons that express the gene Ppp1r1b in the posterior of the basolateral amygdala (pBLA), a region known to assign associations of aversive or rewarding feelings, or valence, with memories. The study was conducted by Xiangyu Zhang, a graduate student, Joshua Kim, a former graduate student, and Susumu Tonegawa, Professor of Biology and Neuroscience at RIKEN-MIT Laboratory of Neural Circuit Genetics at the Picower Institute for Learning and Memory at MIT and Howard Hughes Medical Institute.

We constantly live at the balance of positive and negative emotion, Tonegawa said. We need to have very strong memories of dangerous circumstances in order to avoid similar circumstances to recur. But if we are constantly feeling threatened, we can become depressed. You need a way to bring your emotional state back to something more positive.

Overriding fear with reward

In a prior study, Kim showed that Ppp1r1b-expressing neurons encode rewarding valence and compete with distinct Rspo2-expressing neurons in the BLA that encode negative valence. In the new study, Zhang, Kim and Tonegawa set out to determine whether this competitive balance also underlies fear and its extinction.

In fear extinction, an original fearful memory is thought to be essentially overwritten by a new memory that is not fearful. In the study, for instance, mice were exposed to little shocks in a chamber, making them freeze due to the formation of fearful memory. But the next day, when the mice were returned to the same chamber for a longer period of time without any further little shocks, freezing gradually dissipated and hence this treatment is called fear extinction training. The fundamental question then is whether the fearful memory is lost or just suppressed by the formation of a new memory during the fear extinction training.

While the mice underwent fear extinction training the scientists watched the activity of the different neural populations in the BLA. They saw that Ppp1r1b cells were more active and Rspo2 cells were less active in mice that experienced fear extinction. They also saw that while Rspo2 cells were mostly activated by the shocks and were inhibited during fear extinction, Ppp1r1b cells were mostly active during extinction memory training and retrieval but were inhibited during the shocks.

These and other experiments suggested to the authors that the hypothetical fear extinction memory may be formed in the Ppp1r1b neuronal population and the team went on to demonstrate this vigorously. For this, they employed the technique previously pioneered in their lab for the identification and manipulation of the neuronal population that holds specific memory information, memory engram cells. Zhang labeled Ppp1r1b neurons that were activated during retrieval of fear extinction memory with the light-sensitive protein channel rhodopsin. When these neurons were activated by blue laser light during a second round of fear extinction training it enhanced and accelerated the extinction. Moreover, when the engram cells were inhibited by another optogenetic technique, fear extinction was impaired because the Ppp1r1b engram neurons could no longer suppress the Rspo2 fear neurons. That allowed the fear memory to regain primacy.

These data met the fundamental criteria for the existence of engram cells for fear extinction memory within the pBLA Ppp1r1b cell population: activation and reactivation by recall and enduring and off-line maintenance of the acquired extinction memory.

Because Kim had previously shown Ppp1r1b neurons are activated by rewards and drive appetitive behavior and memory, the team sequentially tracked Ppp1r1b cell activity in mice that eagerly received water reward followed by food reward followed by fear extinction training and fear extinction memory retrieval. The overlap of Ppp1r1b neurons activated by fear extinction vs. water reward was as high as the overlap of neurons activated by water vs. food reward.

And finally, artificial optogenetic activation of Ppp1r1b extinction memory engram cells was as effective as optogenetic activation of Ppp1r1b water reward-activated neurons in driving appetitive behaviors. Reciprocally, artificial optogenetic activation of water-responding Ppp1r1b neurons enhanced fear extinction training as efficiently as optogenetic activation of fear extinction memory engram cells. These results demonstrate that fear extinction is equivalent to bona fide rewards and therefore provide the neuroscientific basis for the widely held experience in daily life: omission of expected punishment is a reward.

What next?

By establishing this intimate connection between fear extinction and reward and by identifying a genetically defined neuronal population (Ppp1r1b) that plays a crucial role in fear extinction this study provides potential therapeutic targets for treating fear disorders like PTSD and anxiety, Zhang said.

From the basic scientific point of view, Tonegawa said, how fear extinction training specifically activates Ppp1r1b neurons would be an important question to address. More imaginatively, results showing how Ppp1r1b neurons override Rspo2 neurons in fear extinction raises an intriguing question about whether a reciprocal dynamic might also occur in the brain and behavior. Investigating joy extinction via these mechanisms might be an interesting research topic.

Reference

Zhang et al. (2020) Amygdala Reward Neurons Form and Store Fear Extinction Memory. Neuron. DOI: https://doi.org/10.1016/j.neuron.2019.12.025

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read more:
Connecting Fear and Reward in the Mammalian Brain - Technology Networks

Phoenix Childrens Is the First-Ever Health System in the U.S to Use Medtronic Stealth Autoguide Cranial Robotic Guidance Platform for Neurosurgery -…

Pediatric Health System First to Use Groundbreaking Cranial Robotic System in a Patient Surgery

DUBLIN and PHOENIX, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Nationally ranked pediatric leader, Phoenix Childrens Hospital, is the first-ever health system in the U.S. to receive and deploy the newly FDA-cleared Medtronic Stealth Autoguide platform. Medtronic, a global leader in medical technology, chose Barrow Neurological Institute (BNI) at Phoenix Childrens as its first partner using this robotic technology. The highly advanced surgical tool is intended for use with the Medtronic StealthStation system, and Phoenix Childrens Hospital will use it in surgery for pediatric patients suffering from a range of neurological conditions.

Phoenix Childrens is proud to invest in the best possible technology for use while we provide outstanding care to children, said Daniel Ostlie, M.D., surgeon in chief and chair of Surgery at Phoenix Childrens. We are committed to being at the forefront of surgical innovation and having the most advanced solutions for pediatric patients.

BNI at Phoenix Childrens surgical staff have undergone comprehensive training with the Medtronic team as they prepared to use the Stealth Autoguide robotic guidance system in patient neurosurgery cases in early January.

The Stealth Autoguide is a tremendous addition to the neurosurgical teams tools at Phoenix Childrens, said P. David Adelson, division chief of Neurosurgery and director of BNI at Phoenix Childrens. Neurosurgery is such an intricate specialty, and having this technology at our fingertips perfectly aligns with our mission to provide state-of-the-art care to improve the health and quality of life for the children we see here.

Ranked a top pediatric neuroscience, neurosurgery and neurology program by U.S. News & World Reports Best Childrens Hospitals, BNI at Phoenix Childrens is eager to combine its deep bench of clinical talent with Medtronics cutting-edge innovation.

With our new technology deployed, we are thrilled to work with Phoenix Childrens and to support their mission of providing exceptional care for pediatric patients, said Dave Anderson, vice president and general manager, Enabling Technologies, which is part of the Restorative Therapies Group at Medtronic.

Phoenix Childrens Hospital Foundation received funding for the Stealth Autoguide from close community partners who support Phoenix Childrens in providing the best care by advancing pediatric medical solutions.

"We are extremely appreciative of the communitys support of the Stealth Autoguide, said Steve Schnall, senior vice president at Phoenix Children's Hospital Foundation. We are grateful to the Del E. Webb Foundation, Thunderbirds Charities, and WINGS, the womens auxiliary board of Phoenix Childrens, for investing in this state-of-the-art technology."

About Phoenix Childrens HospitalPhoenix Childrens Hospital is Arizonas only childrens hospital recognized by U.S. News & World Reports Best Childrens Hospitals with rankings in all ten specialties. Phoenix Children's provides world-class inpatient, outpatient, trauma, emergency and urgent care to children and families in Arizona and throughout the Southwest. As one of the largest childrens hospitals in the country, Phoenix Childrens provides care across more than 75 pediatric specialties. The Hospital is poised for continued growth in quality patient care, research and medical education. For more information about the hospital, visithttp://www.phoenixchildrens.org.

About Barrow Neurological Institute at Phoenix Children's HospitalBarrow Neurological Institute at Phoenix Children's Hospital heals children with neurological and mental health diseases and disorders so that they can have a happy and healthy quality of life by offering the most comprehensive inpatient and outpatient neurological care and services to infants, children and teens. Recognized by U.S. News & World Report as a leading Neuroscience Center for our collaborative and comprehensive approach to clinical medicine, Barrow at Phoenix Children's is largest pediatric neuroscience center in the Southwest. This is due in large part to BNIs commitment to education and research, along with the integration of pediatric neurosurgery, neurology, psychology, psychiatry, neurodevelopmental pediatrics and rehabilitation in the global care of children. Specialized medical equipment, pediatric patient rooms and pediatric specialists, in addition to a family-centered focus, make the institute and hospital uniquely qualified to treat complex neurological disorders in pediatric patients. For more information, visit:http://barrow.phoenixchildrens.org.

Story continues

About Stealth AutoguideTheMedtronic Stealth Autoguideis designed for accurate positioning of instruments to support a variety of neurological procedures. The technology can generally be used as a tool during stereoelectroencephalographies (sEEG), biopsies, and Visualase procedures. The Stealth Autoguide combines advanced software, navigation and instrumentation to enable accuracy during surgical procedures.

About MedtronicMedtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the worlds largest medical technology, services and solutions companies alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

David T. YoungMedtronic plcPublic Relations+1-774-248-2746

Ryan WeispfenningMedtronic plcInvestor Relations+1-763-505-4626

Erica SturwoldPhoenix ChildrensMedia Relations+1-602-933-5871

Original post:
Phoenix Childrens Is the First-Ever Health System in the U.S to Use Medtronic Stealth Autoguide Cranial Robotic Guidance Platform for Neurosurgery -...

Nerve Stimulation Therapy Could Cut Fibromyalgia Pain – HealthDay

THURSDAY, Jan. 16, 2020 (HealthDay News) -- For people with the mysterious chronic pain condition fibromyalgia, researchers say nerve stimulation may offer some relief.

In a recent study, use of TENS -- transcutaneous electrical nerve stimulation -- during movement or activity was shown to significantly reduce pain associated with fibromyalgia after just four weeks.

Dr. Lesley Arnold, who was not involved with the new study, lauded its outcomes. "The improvements in pain and fatigue were remarkable," she said. Arnold, a professor of psychiatry and behavioral neuroscience at the University of Cincinnati College of Medicine, suggested that the study may help guide physicians in use of TENS for symptom management.

TENS uses a battery-operated machine to deliver electrical currents via electrodes attached to the skin. This is believed to activate nerve pathways that inhibit pain.

People with fibromyalgia are encouraged to engage in physical activity as a way to manage their symptoms. But, paradoxically, movement can be painful for them.

In the study, researchers randomly divided more than 300 women with fibromyalgia into three groups: active TENS; placebo (sham) TENS; or no TENS. Those in the TENS groups were instructed to use the device over four weeks, at home, for two hours daily during activity. The patients were told to apply the device's electrodes to two specific areas along the back -- one upper and one lower -- and to activate the machine at a modulated, or varying, frequency at the highest intensity bearable.

After four weeks, participants in the active-TENS group reported significant reductions in movement-and-resting pain and fatigue, especially compared to the no-TENS group.

Lead study author Kathleen Sluka, a University of Iowa research professor, said this study represents the culmination of years of animal research in which she and co-investigators experimented with variations in the use of TENS. Over time, the investigators learned that alternating between low and high frequency worked best to provide pain relief. So too did cranking up the machine to its highest intensity possible. "Strong, but not painful," she said.

While Sluka sees promise in the study's results, she was careful to note that TENS is not a cure for fibromyalgia.

"This is another tool that's not a drug that patients can use to manage their pain," one that may allow someone to reach for something other than ibuprofen or opioids as a first line of defense, Sluka said.

That TENS is readily available and comes with minimal risk also make it appealing. TENS devices can be bought over-the-counter at pharmacies for less than $50. As far as adverse effects, slight irritation at the site where the electrodes were applied was the primary adverse effect reported. And that is minor and easily adjustable, Sluka noted.

Superstar Lady Gaga shined a light on fibromyalgia when she canceled several concert tour dates in 2017 and 2018 due to reported flare-ups.

The condition is believed to affect about 10 million Americans, according to the National Fibromyalgia Association.

As researchers continue to look for safe and effective ways to alleviate the pain of fibromyalgia, much about it remains a mystery.

Diagnosis is usually based on a patient's medical history and exam; there's no blood test or other biomarker to identify it. And while its biological origins are unclear, most experts believe it is associated with alterations in the central nervous system that affect how the body responds to pain.

Management of the condition, which affects women disproportionately, has improved in recent years, said Arnold. It's being identified earlier; general awareness of the condition has improved; and, recently, a few medications have been approved by the U.S. Food and Drug Administration to manage it.

"But there's still a great deal of unmet need," Arnold said.

The report was recently published online in the journal Arthritis & Rheumatology.

More information

There's more on fibromyalgia at the National Fibromyalgia Association.

SOURCES: Kathleen Sluka, P.T., Ph.D., research professor, University of Iowa, Iowa City; Lesley Arnold, M.D., professor, psychiatry and behavioral neuroscience, University of Cincinnati College of Medicine; Nov. 18, 2019, Arthritis & Rheumatology, online

See the rest here:
Nerve Stimulation Therapy Could Cut Fibromyalgia Pain - HealthDay